There are ongoing genetic engineering trials that aim to address BRCA1 and BRCA2 mutations in high-risk women. Some of these include: CRISPR gene editing to develop a treatment for BRCA1-related breast cancer, Gene therapy, which involves introducing a healthy copy of the BRCA1 or BRCA2 gene into cells to restore their function, RNA interference to target and silence the mutated BRCA1 or BRCA2 genes and block the expression of specific genes, Synthetic lethality to selectively kill cancer cells with BRCA1 or BRCA2 mutations while sparing healthy cells…. Read More »